InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,101.95
(
1.06%
)
US TECH 100
17,268.00
(
1.71%
)
Dow Jones
38,256.95
(
0.45%
)
Brent Oil
88.16
(
0.01%
)
Bitcoin
63,863.42
(
-0.96%
)
Post# of 4856
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

crowin

Send PM Follow Ignore
Followers 434
Posts 28584
Boards Moderated 3
Alias Born 02/19/2005

crowin

Re: None

Monday, 09/12/2016 9:36:27 PM

Monday, September 12, 2016 9:36:27 PM

Post# of 4856
On September 12, 2016, Neuralstem, Inc. (the “Company”) announced that Dr. Karl Johe, Ph.D., the Company’s chief scientific officer presented the poster “Therapeutic Efficacy of NSI-189 in Diabetic Mice,” at the Annual Meeting of the Diabetic Neuropathy Study Group of the EASD (European Association for the Study of Diabetes), held in Bucharest, Romania, on September 11, 2016. A copy of the press release is attached to this report as Exhibit 99.01.

http://ih.advfn.com/p.php?pid=nmona&article=72411596&symbol=CUR
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up